13
Stanford University Noninvasive and Targeted Brain Drug Delivery using Transcranial Focused Ultrasound 1/43 Muna Aryal, PhD Department of Radiology Mentors: Drs. Raag Airan & Jeremy Dahl SCIT Seminar July 31, 2019

Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Noninvasive and Targeted Brain Drug Delivery using Transcranial Focused Ultrasound

1/43

Muna Aryal, PhDDepartment of Radiology

Mentors: Drs. Raag Airan & Jeremy Dahl

SCIT SeminarJuly 31, 2019

Page 2: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Outline

v Existing Approaches for Brain Drug Delivery1. Vascular Opening

(Focused Ultrasound + Microbubbles)

2. Without Vascular Opening(Focused Ultrasound + Nanodroplets)

v New Approach for Brain Drug Delivery

vConclusions

Page 3: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Brain’s Fluid Compartments and Barriers

1. Cerebrospinal fluid: 10%2. Blood vasculature: 10%3. Interstitial fluid: 12-20% 4. Intracellular fluid: 60-68%

Page 4: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Brain’s Fluid Compartments and Barriers

1. Cerebrospinal fluid: 10%2. Blood vasculature: 10%3. Interstitial fluid: 12-20% 4. Intracellular fluid: 60-68%

Blood-Brain Barrier (BBB)

Blood-CSF Barrier (BCSFB)

Page 5: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

However, those vascular barriers, the BBB, and the BCSFB limit drug delivery for neurological disorders.

Page 6: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford UniversityAryal et al. Advanced Drug Delivery Review; 2014

v Direct Injectionv Implantable devices v Intrathecal/Intraventicular Injectionv BBBD via arterial injection of osmotic solution

• Invasive

• Trans-Nasal Delivery

• Biopharmaceutical

• New: Focused Ultrasound

Approaches for Brain Drug Delivery

Page 7: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Vascular Opening

Page 8: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Vascular Opening

ü FDA approved for phase 0/1 trial in brain cancer and alzheimer

Page 9: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Without Vascular Opening

Page 10: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Without Vascular Opening

Aryal* & Wang* et al., Neuron. 2018, * equally contributedZhong et al., Biomaterials. 2019

ü Preclinical models for neuroscience and cancer applications

Page 11: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Left Right

35 min

Left Right

70 minC

ontr

ol C

ohor

t FU

S C

ohor

t

Left Right FUS Left

RightFUS

0

20

40

60

80

100

120

0 35 70 105

Gad

olin

ium

Enh

ance

d Vo

lum

e (m

m3 )

Time After Gadolinium Injection (Min)

Control Cohort: Right Side Control Cohort: Left SideFUS Cohort: Left Side (Non-Treated)FUS Cohort: Right Side (Treated)

ns*

**

***

*****

105 min

Left Right

LeftRightFUS

Normalized Contrast-Enhanced T1-weighted Magnetic Resonance Images of rat brain

Note: black colored stars & ns: two tailed paired t-test between left (non-treated) and right(treated) hemisphere of the brain in FUS cohortsblue colored stars & ns: two tailed unpaired ttest between Control and FUS Cohort of right hemispheres

Page 12: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Acknowledgement

Airan’s Lab

Ø Laura J. PisaniØ Frezghi G. HabteØ Aurea Pascal-TenorioØ Niloufar Hosseini Nassab

Page 13: Noninvasive and Targeted Brain Drug Delivery using Transcranial …med.stanford.edu/content/dam/sm/scitprogram/documents/seminar_… · 1.Cerebrospinal fluid: 10% 2.Blood vasculature:

Stanford University

Thank you